Globus Medical (GMED) Competitors $82.54 -0.88 (-1.05%) (As of 11/13/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GMED vs. EW, RMD, IDXX, DXCM, STE, PODD, BAX, HOLX, TFX, and MASIShould you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Teleflex (TFX), and Masimo (MASI). These companies are all part of the "health care equipment" industry. Globus Medical vs. Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Baxter International Hologic Teleflex Masimo Globus Medical (NYSE:GMED) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability. Do institutionals & insiders hold more shares of GMED or EW? 95.2% of Globus Medical shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 18.5% of Globus Medical shares are held by company insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher valuation & earnings, GMED or EW? Edwards Lifesciences has higher revenue and earnings than Globus Medical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobus Medical$1.57B7.13$122.87M$0.67123.20Edwards Lifesciences$6.31B6.21$1.40B$6.939.60 Which has more risk and volatility, GMED or EW? Globus Medical has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Does the MarketBeat Community believe in GMED or EW? Edwards Lifesciences received 767 more outperform votes than Globus Medical when rated by MarketBeat users. Likewise, 71.05% of users gave Edwards Lifesciences an outperform vote while only 67.84% of users gave Globus Medical an outperform vote. CompanyUnderperformOutperformGlobus MedicalOutperform Votes56167.84% Underperform Votes26632.16% Edwards LifesciencesOutperform Votes132871.05% Underperform Votes54128.95% Do analysts rate GMED or EW? Globus Medical currently has a consensus price target of $88.18, indicating a potential upside of 6.83%. Edwards Lifesciences has a consensus price target of $75.67, indicating a potential upside of 13.75%. Given Edwards Lifesciences' higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Globus Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globus Medical 1 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.58Edwards Lifesciences 0 Sell rating(s) 16 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.38 Is GMED or EW more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Globus Medical's net margin of 3.69%. Edwards Lifesciences' return on equity of 20.76% beat Globus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Globus Medical3.69% 9.98% 7.92% Edwards Lifesciences 70.82%20.76%15.27% Does the media refer more to GMED or EW? In the previous week, Edwards Lifesciences had 26 more articles in the media than Globus Medical. MarketBeat recorded 53 mentions for Edwards Lifesciences and 27 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.66 beat Edwards Lifesciences' score of 0.29 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 7 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 1 Positive mention(s) 32 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryEdwards Lifesciences beats Globus Medical on 11 of the 18 factors compared between the two stocks. Ad Weiss RatingsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GMED vs. The Competition Export to ExcelMetricGlobus MedicalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.18B$4.62B$5.15B$19.96BDividend YieldN/A39.52%5.03%3.50%P/E Ratio123.2015.3391.9139.59Price / Sales7.1362.651,297.7118.19Price / Cash23.1352.4439.3421.68Price / Book2.755.616.424.66Net Income$122.87M$13.58M$114.95M$982.08M7 Day Performance-0.19%-0.87%-0.76%-0.26%1 Month Performance16.97%7.11%4.85%2.02%1 Year Performance88.54%55.84%41.33%30.64% Globus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GMEDGlobus Medical4.6545 of 5 stars$82.55-1.1%$88.18+6.8%+88.5%$11.18B$1.57B123.205,000Analyst ForecastEWEdwards Lifesciences4.5827 of 5 stars$66.23+0.6%N/A+3.0%$39.06B$6.31B9.5619,800Insider SellingShort Interest ↓RMDResMed4.7636 of 5 stars$252.38+1.5%N/A+64.8%$37.05B$4.81B33.439,980Positive NewsIDXXIDEXX Laboratories4.8875 of 5 stars$433.28+0.1%N/A-0.6%$35.48B$3.66B41.7811,000Short Interest ↓Positive NewsDXCMDexCom4.9844 of 5 stars$69.96+1.5%N/A-26.3%$26.80B$3.62B41.899,600Short Interest ↑Positive NewsSTESTERIS4.9587 of 5 stars$219.19+1.7%N/A+9.9%$21.62B$5.14B50.0418,179Earnings ReportShort Interest ↓PODDInsulet4.4267 of 5 stars$268.00+9.4%N/A+64.4%$18.79B$1.70B48.733,000Analyst ForecastAnalyst RevisionGap UpHigh Trading VolumeBAXBaxter International4.8027 of 5 stars$34.64-3.9%N/A-3.2%$18.42B$14.81B7.1360,000Earnings ReportDividend CutAnalyst ForecastShort Interest ↓High Trading VolumeHOLXHologic4.8882 of 5 stars$78.76-0.7%N/A+10.9%$18.29B$4.03B23.656,990Short Interest ↓Analyst RevisionTFXTeleflex4.941 of 5 stars$195.55-1.3%N/A-4.8%$9.08B$2.97B38.8814,500Analyst UpgradeAnalyst RevisionMASIMasimo4.1106 of 5 stars$162.41+0.7%N/A+83.2%$8.64B$2.05B112.015,200 Related Companies and Tools Related Companies Edwards Lifesciences Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Teleflex Alternatives Masimo Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GMED) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
